12 neoplasia I

download 12 neoplasia I

of 51

Transcript of 12 neoplasia I

  • 8/7/2019 12 neoplasia I

    1/51

    Neoplasia IIntroduction

    Husni Maqboul, M.D.

  • 8/7/2019 12 neoplasia I

    2/51

    Terminology

    Tumor : Pathologic disturbance of growth,

    characterized by excessive and unnecessary

    proliferation of cells

    Galen (131 - 201 AD )

    Swelling according to nature ( pregnancy )

    Swelling exceeding nature ( Callus )

    Swelling contrary to nature

  • 8/7/2019 12 neoplasia I

    3/51

    Terminology

    Hamartoma : Excessive but focal

    overgrowth of cells and tissues native to the

    organ in which it occurs. Cellular elements

    are mature, but do not produce normal

    architecture

    Hamartroma of lung

    Angiomas

    Pigmented nevi

  • 8/7/2019 12 neoplasia I

    4/51

    Terminology

    Choristoma (Heterotopia) : Normal cells or tissues,

    that are present in abnormal locations

    Pancreatic cells in the wall of stomach or

    intestine

    Nests of adrenal cells in kidney , lung or ovaries

  • 8/7/2019 12 neoplasia I

    5/51

    Terminology

    Neoplasms : Persistent , abnormal and

    relatively autonomous proliferation of cells

    occurring as a result of permanent cellular

    defect that is passed to the progeny. Usually

    develops due to a factor(s) , but once

    developed , becomes independent of them.

  • 8/7/2019 12 neoplasia I

    6/51

    Types of neoplasms

    Neoplasms

    Parenchyma made up of neoplastic cells

    Supporting host derived stroma

    Benign: localized and amenable to surgicalremoval; patient usually survives

    Malignant: invasive tumor capable ofdestroying structures and spread to distantsites (metastasis); may result in early deathof the patient

  • 8/7/2019 12 neoplasia I

    7/51

    Examples of benign tumors

    Epithelial

    Adenoma: benign glandular tumorPapilloma : benign surface epithelial tumors

    Polyp : benign tumor projecting over mucosal

    surface

    Cystadenoma : benign epithelial tumor forming

    hollow cystic mass

  • 8/7/2019 12 neoplasia I

    8/51

    Examples of benign tumors

    Mesenchymal

    Chondroma: benign cartilaginous tumor

    Leiomyoma: benign smooth muscle tumor

    lipoma: benign tumor of fat Fibroma: benign tumor of fibrous tissue

    Mixed

    Benign Mixed Tumor divergent differentiation of stem

    cell (pleomorphic adenoma) Fibroadenoma neoplastic fibrous component

    More than one germ cell layer

    Benign teratoma mature components

  • 8/7/2019 12 neoplasia I

    9/51

    leiomyomas

  • 8/7/2019 12 neoplasia I

    10/51

    adenoma

  • 8/7/2019 12 neoplasia I

    11/51

    Examples of malignant tumors

    Sarcoma (mesenchymal derivation: fibrosarcoma,

    chondrosarcoma) Carcinoma (epithelial derivation: adenocarcinoma,

    squamous cell carcinoma)

    Squamous

    Adeno Transitional

    Lymphoma/leukemia

  • 8/7/2019 12 neoplasia I

    12/51

    adenocarcinoma

  • 8/7/2019 12 neoplasia I

    13/51

    carcinoma

  • 8/7/2019 12 neoplasia I

    14/51

    The terms benign and malignant

    describe the biologic behavior of a tumor

    The biologic behavior is characterized by

    degree of differentiation of the tumor , rate

    of growth (and rate of cell death) ,

    infiltration of surrounding tissue, anddissemination to distant sites

  • 8/7/2019 12 neoplasia I

    15/51

  • 8/7/2019 12 neoplasia I

    16/51

    D

    ifferentiation

    Well-differentiated tumors contain cells that

    resemble the normal cells of origin

    Poorly-differentiated or undifferentiated

    tumors contain cells that do not resemble

    their normal counterparts (ancillary studies

    may be needed to determine the cell oforigin)

  • 8/7/2019 12 neoplasia I

    17/51

    well-differentiated

  • 8/7/2019 12 neoplasia I

    18/51

    poorly-differentiated

  • 8/7/2019 12 neoplasia I

    19/51

    Benign tumors are composed of well-

    differentiated cells.

    Malignant tumors are characterized by a

    wide range of cellular differentiation.

    Anaplasia (cellular pleomorphism,

    hyperchromatic nuclei, high N:C ratio, giantcells, bizarre nuclei) is a feature of

    malignant tumors.

    Differentiation

  • 8/7/2019 12 neoplasia I

    20/51

    anaplasia

  • 8/7/2019 12 neoplasia I

    21/51

    D

    ysplasia denotes a loss of architectural organization

    and a loss of cell uniformity in epithelium

    pleomorphism and mitoses are moreprominent than in the normal

    usually graded: mild, moderate, severe, and

    carcinoma-in-situ mild to moderate dysplasia is potentially

    reversible

  • 8/7/2019 12 neoplasia I

    22/51

    normal epithelium

  • 8/7/2019 12 neoplasia I

    23/51

    dysplasia

  • 8/7/2019 12 neoplasia I

    24/51

    D

    ysplasia

    Dysplasia is a non-neoplastic proliferation. Dysplasia may or may not progress to

    cancer.

  • 8/7/2019 12 neoplasia I

    25/51

    R

    ate of grow

    th

    In general, benign and well-differentiated

    malignant tumors have a slower rate of

    growth than moderately-differentiated and

    poorly-differentiated malignant tumors.

    There are exceptions. Blood supply, site,

    and hormonal stimulation are factors thatcan affect the growth rate of tumors.

  • 8/7/2019 12 neoplasia I

    26/51

    I

    nvasion

    Benign tumors usually grow by slow

    expansion.

    Malignant tumors usually infiltrate and may

    destroy surrounding tissue (cell surface and

    the extracellular matrix play an important

    role).

  • 8/7/2019 12 neoplasia I

    27/51

    F

    unctional characteristics

    Benign tumors are more likely to function

    Epithelial tumors can produce mucin Hormonal production can be unregulated

    Inappropriate production of hormones by

    different type of cells Abnormal receptor and antigenic expression

  • 8/7/2019 12 neoplasia I

    28/51

    M

    etastasis

    indicates malignancy

    a discontinuous spread of the tumor Methods of metastasis include: (1)seeding

    of body cavities, (2) lymphatic spread, and

    (3) hematogenous spread.

  • 8/7/2019 12 neoplasia I

    29/51

    metastatic ovarian carcinoma

  • 8/7/2019 12 neoplasia I

    30/51

    MRI: metastatic adenocarcinoma

  • 8/7/2019 12 neoplasia I

    31/51

    metastatic adenocarcinoma

  • 8/7/2019 12 neoplasia I

    32/51

    Grading and staging

    Grading is based on the microscopic

    features of the cells which compose a tumor

    and is specific for the tumor type.

    Staging is based on clinical, radiological,

    and surgical criteria, such as, tumor size,

    involvement of regional lymph nodes, andpresence of metastases. Staging usually has

    more prognostic value.

  • 8/7/2019 12 neoplasia I

    33/51

    Morbidity and mortality

    metastases

    rupture into major vessels compression of vital organs

    organ failure

    infection

  • 8/7/2019 12 neoplasia I

    34/51

    meningioma

  • 8/7/2019 12 neoplasia I

    35/51

    basal cell carcinoma

  • 8/7/2019 12 neoplasia I

    36/51

    melanoma

  • 8/7/2019 12 neoplasia I

    37/51

    Diagnostic procedures

    FNA (fine needle aspiration)

    Cytological smears Biopsy

    Frozen sections

    Biochemical assays Molecular diagnosis

    Flow cytometry

  • 8/7/2019 12 neoplasia I

    38/51

    cytology smear: adenocarcinoma

  • 8/7/2019 12 neoplasia I

    39/51

    Pap smearwith dysplasia

  • 8/7/2019 12 neoplasia I

    40/51

    frozen section

  • 8/7/2019 12 neoplasia I

    41/51

    staining a frozen section

  • 8/7/2019 12 neoplasia I

    42/51

    Ancillary studies

    Immunohistochemistry

    Cytogenetics Flow cytometry

    Electron microscopy

  • 8/7/2019 12 neoplasia I

    43/51

    cytokeratin stain on a carcinoma

  • 8/7/2019 12 neoplasia I

    44/51

    AFPstain on a yolk sac tumor

  • 8/7/2019 12 neoplasia I

    45/51

    EM:neurosecretory granules

  • 8/7/2019 12 neoplasia I

    46/51

    EM: microvilli, tight junction in

    an adenocarcinoma

  • 8/7/2019 12 neoplasia I

    47/51

    Biochemical assays

    Tumor markers: sometimes diagnostic or

    prognostic

    Can be helpful in monitoring effectiveness

    of therapy or in detecting

    relapses/recurrences

  • 8/7/2019 12 neoplasia I

    48/51

  • 8/7/2019 12 neoplasia I

    49/51

    Summary

    Neoplasia- an abnormal mass of tissue

    which has lost its responsiveness to growth

    controls

    Benign neoplasms tend to be slow-growing,

    well-differentiated tumors which lack the

    ability to metastasize

    Benign neoplasms, in general, remain

    localized and are amenable to surgery

  • 8/7/2019 12 neoplasia I

    50/51

    Summary

    Malignant neoplasms tend to be fast-

    growing lesions which invade normal

    structures

    Malignant neoplasms vary in the degree of

    differentiation and some show anaplasia

    Malignant neoplasms are capable ofmetastasis

  • 8/7/2019 12 neoplasia I

    51/51

    Summary

    The prognosis of a patient with any type of

    neoplasm depends on a number of factors

    including: the rate of growth of the tumor,

    the size of the tumor, the tumor site, the cell

    type and degree of differentiation, the

    presence of metastasis, responsiveness totherapy, and the general health of the

    patient.